205 related articles for article (PubMed ID: 25552727)
1. Development of a mouse-adapted live attenuated influenza virus that permits in vivo analysis of enhancements to the safety of live attenuated influenza virus vaccine.
Cox A; Baker SF; Nogales A; Martínez-Sobrido L; Dewhurst S
J Virol; 2015 Mar; 89(6):3421-6. PubMed ID: 25552727
[TBL] [Abstract][Full Text] [Related]
2. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
[TBL] [Abstract][Full Text] [Related]
3. Safety, immunogenicity and infectivity of new live attenuated influenza vaccines.
Isakova-Sivak I; Rudenko L
Expert Rev Vaccines; 2015; 14(10):1313-29. PubMed ID: 26289975
[TBL] [Abstract][Full Text] [Related]
4. Development of a high-yield live attenuated H7N9 influenza virus vaccine that provides protection against homologous and heterologous H7 wild-type viruses in ferrets.
Chen Z; Baz M; Lu J; Paskel M; Santos C; Subbarao K; Jin H; Matsuoka Y
J Virol; 2014 Jun; 88(12):7016-23. PubMed ID: 24719414
[TBL] [Abstract][Full Text] [Related]
5. A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.
Talaat KR; Karron RA; Callahan KA; Luke CJ; DiLorenzo SC; Chen GL; Lamirande EW; Jin H; Coelingh KL; Murphy BR; Kemble G; Subbarao K
Vaccine; 2009 Jun; 27(28):3744-53. PubMed ID: 19464558
[TBL] [Abstract][Full Text] [Related]
6. Temperature Sensitive Mutations in Influenza A Viral Ribonucleoprotein Complex Responsible for the Attenuation of the Live Attenuated Influenza Vaccine.
Martínez-Sobrido L; Peersen O; Nogales A
Viruses; 2018 Oct; 10(10):. PubMed ID: 30326610
[TBL] [Abstract][Full Text] [Related]
7. Live attenuated influenza vaccine in children.
Ambrose CS; Walker RE; Connor EM
Semin Pediatr Infect Dis; 2006 Oct; 17(4):206-12. PubMed ID: 17055372
[TBL] [Abstract][Full Text] [Related]
8. Development of a dual-protective live attenuated vaccine against H5N1 and H9N2 avian influenza viruses by modifying the NS1 gene.
Choi EH; Song MS; Park SJ; Pascua PN; Baek YH; Kwon HI; Kim EH; Kim S; Jang HK; Poo H; Kim CJ; Choi YK
Arch Virol; 2015 Jul; 160(7):1729-40. PubMed ID: 25959557
[TBL] [Abstract][Full Text] [Related]
9. Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children.
King JC; Fast PE; Zangwill KM; Weinberg GA; Wolff M; Yan L; Newman F; Belshe RB; Kovacs A; Deville JG; Jelonek M;
Pediatr Infect Dis J; 2001 Dec; 20(12):1124-31. PubMed ID: 11740317
[TBL] [Abstract][Full Text] [Related]
10. Pandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus.
Rudenko L; Isakova-Sivak I
Expert Rev Vaccines; 2015 Mar; 14(3):395-412. PubMed ID: 25555687
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous administration of live, attenuated influenza A vaccines representing different serotypes.
Wright PF; Bhargava M; Johnson PR; Thompson J; Karzon DT
Vaccine; 1985 Sep; 3(3):305-8. PubMed ID: 3904259
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and effectiveness of live attenuated influenza vaccine in school-age children.
Coelingh K; Olajide IR; MacDonald P; Yogev R
Expert Rev Vaccines; 2015; 14(10):1331-46. PubMed ID: 26372891
[TBL] [Abstract][Full Text] [Related]
13. A Single Mutation at PB1 Residue 319 Dramatically Increases the Safety of PR8 Live Attenuated Influenza Vaccine in a Murine Model without Compromising Vaccine Efficacy.
Cox A; Dewhurst S
J Virol; 2015 Dec; 90(5):2702-5. PubMed ID: 26676793
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and safety of a quadrivalent live attenuated influenza vaccine in children.
Block SL; Falloon J; Hirschfield JA; Krilov LR; Dubovsky F; Yi T; Belshe RB
Pediatr Infect Dis J; 2012 Jul; 31(7):745-51. PubMed ID: 22466322
[TBL] [Abstract][Full Text] [Related]
15. Novel Approaches for The Development of Live Attenuated Influenza Vaccines.
Blanco-Lobo P; Nogales A; Rodríguez L; Martínez-Sobrido L
Viruses; 2019 Feb; 11(2):. PubMed ID: 30813325
[TBL] [Abstract][Full Text] [Related]
16. Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model.
Isakova-Sivak I; Korenkov D; Smolonogina T; Tretiak T; Donina S; Rekstin A; Naykhin A; Shcherbik S; Pearce N; Chen LM; Bousse T; Rudenko L
Virology; 2017 Jan; 500():209-217. PubMed ID: 27829176
[TBL] [Abstract][Full Text] [Related]
17. A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys.
Min JY; Vogel L; Matsuoka Y; Lu B; Swayne D; Jin H; Kemble G; Subbarao K
J Virol; 2010 Nov; 84(22):11950-60. PubMed ID: 20810733
[TBL] [Abstract][Full Text] [Related]
18. An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults.
Talaat KR; Karron RA; Liang PH; McMahon BA; Luke CJ; Thumar B; Chen GL; Min JY; Lamirande EW; Jin H; Coelingh KL; Kemble GW; Subbarao K
Influenza Other Respir Viruses; 2013 Jan; 7(1):66-73. PubMed ID: 22417012
[TBL] [Abstract][Full Text] [Related]
19. Quadrivalent Ann Arbor strain live-attenuated influenza vaccine.
Toback SL; Levin MJ; Block SL; Belshe RB; Ambrose CS; Falloon J
Expert Rev Vaccines; 2012 Nov; 11(11):1293-303. PubMed ID: 23151111
[TBL] [Abstract][Full Text] [Related]
20. Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age.
Mallory RM; Yi T; Ambrose CS
Vaccine; 2011 Jun; 29(26):4322-7. PubMed ID: 21513761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
